Once again, it bears repeating: this is not a Pfizer issue.
BnT is the company behind the vaccine. Pfizer acquired the rights to be BnT’s development and distribution partner for the vaccine everywhere in the world except in China, HK, Macau and Taiwan. Fosun got the rights to China, HK, Macau and Taiwan.
Why BnT gave the rights to a company that never realistically would be able to distribute the vaccine is beyond me. Obviously, politics were involved.
Again, I think it would be cool for Taiwan to make BnT look dumb and put it in the hot seat by saying that it’s prepared to offer $1.5 billion US for 46 million doses of the vaccine, to be purchased directly from Pfizer, not Fosun. This would be more than the price paid per dose by Israel.
Taiwan could also sweeten the deal by guaranteeing that it would buy future booster doses at the same price if boosters are needed.
If BnT was smart, with such an offer in hand, it could try to pay Fosun on the backend to stand aside. BnT is publicly traded so losing out on $1.5 billion in sales from a small country, plus future booster sales, is something shareholders might not be too happy about.
And then Taiwan should go to Moderna and up its order to cover the entire populatio and offer a premium to make sure it’s a priority and send a message to BnT that it done f*cked up.